Wistar Wire

Ben Leach
This month, we cover updates in the field of HIV and AIDS research and the new Wistar Ambassadors program as well as cover the important news and events concerning The Wistar Institute.
glester
Molecular models of the LIMD2 protein.
Molecular models of the LIMD2 protein.
Metastasis is the tipping point, when a malignant tumor goes from bad to nearly unstoppable. Recently, the laboratory of Wistar's Frank Rasucher, III, Ph.D., announced their discovery of what may be a potent driver for metastasis, a protein called LIMD2. Learn more about how LIMD2 might represent a new era in stopping the spread of cancer.
Cancer
glester
Russel E. Kaufman, M.D.
Russel E. Kaufman, M.D.
Wistar's President and CEO, Russel E. Kaufman, M.D., comments on what the potential loss of tobacco dollar-driven CURE program might mean to medical research at Wistar and across Pennsylvania.
Commentary
Ben Leach
The program, which has been provided more than $18 million toward funding research at The Wistar Institute since 2002, experienced severe budget cuts which have threatened research projects across the state.
Cancer